MARSEGLIA, GIUSEPPE
MARSEGLIA, GIUSEPPE
Dipartimento di Scienze degli Alimenti e del Farmaco
A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine
2021-01-01 Ferlenghi, F; Scalvini, L; Vacondio, F; Castelli, R; Bozza, N; Marseglia, G; Rivara, S; Lodola, A; La Monica, S; Minari, R; Petronini, Pg; Alfieri, R; Tiseo, M; Mor, M.
Adolescent gender dysphoria management: position paper from the Italian Academy of Pediatrics, the Italian Society of Pediatrics, the Italian Society for Pediatric Endocrinology and Diabetes, the Italian Society of Adolescent Medicine and the Italian Society of Child and Adolescent Neuropsychiatry
2024-01-01 Calcaterra, V.; Tornese, G.; Zuccotti, G.; Staiano, A.; Cherubini, V.; Gaudino, R.; Fazzi, E. M.; Barbi, E.; Chiarelli, F.; Corsello, G.; Esposito, S. M. R.; Ferrara, P.; Iughetti, L.; Laforgia, N.; Maghnie, M.; Marseglia, G.; Perilongo, G.; Pettoello-Mantovani, M.; Ruggieri, M.; Russo, G.; Salerno, M.; Striano, P.; Valerio, G.; Wasniewska, M.
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma
2021-01-01 Castelli, R.; Taranto, S.; Furiassi, L.; Bozza, N.; Marseglia, G.; Ferlenghi, F.; Rivara, S.; Retini, M.; Bedini, A.; Spadoni, G.; Matarazzo, S.; Ronca, R.; Presta, M.; Mor, M.; Giacomini, A.
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity
2024-01-01 Taranto, Sara; Castelli, Riccardo; Marseglia, Giuseppe; Scalvini, Laura; Vacondio, Federica; Gianoncelli, Alessandra; Ribaudo, Giovanni; Faletti, Jessica; Gazzaroli, Giorgia; Rocca, Edoardo; Ronca, Roberto; Rusnati, Marco; Sacco, Antonio; Roccaro, Aldo Maria; Presta, Marco; Mor, Marco; Giacomini, Arianna; Rivara, Silvia
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines.
2019-01-01 Fumarola, C; Bozza, N; Castelli, R; Ferlenghi, F; Marseglia, Giuseppe; Lodola, A; Bonelli, M; La Monica, S; Cretella, D; Alfieri, R; Minari, R; Galetti, M; Tiseo, M; Ardizzoni, A; Mor, M; Petronini, Pg.
Fibroblast growth factor receptor inhibitors: patent review (2015–2019)
2019-01-01 Marseglia, Giuseppe; Lodola, Alessio; Mor, Marco; Castelli, Riccardo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine | 1-gen-2021 | Ferlenghi, F; Scalvini, L; Vacondio, F; Castelli, R; Bozza, N; Marseglia, G; Rivara, S; Lodola, A; La Monica, S; Minari, R; Petronini, Pg; Alfieri, R; Tiseo, M; Mor, M. | |
| Adolescent gender dysphoria management: position paper from the Italian Academy of Pediatrics, the Italian Society of Pediatrics, the Italian Society for Pediatric Endocrinology and Diabetes, the Italian Society of Adolescent Medicine and the Italian Society of Child and Adolescent Neuropsychiatry | 1-gen-2024 | Calcaterra, V.; Tornese, G.; Zuccotti, G.; Staiano, A.; Cherubini, V.; Gaudino, R.; Fazzi, E. M.; Barbi, E.; Chiarelli, F.; Corsello, G.; Esposito, S. M. R.; Ferrara, P.; Iughetti, L.; Laforgia, N.; Maghnie, M.; Marseglia, G.; Perilongo, G.; Pettoello-Mantovani, M.; Ruggieri, M.; Russo, G.; Salerno, M.; Striano, P.; Valerio, G.; Wasniewska, M. | |
| Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma | 1-gen-2021 | Castelli, R.; Taranto, S.; Furiassi, L.; Bozza, N.; Marseglia, G.; Ferlenghi, F.; Rivara, S.; Retini, M.; Bedini, A.; Spadoni, G.; Matarazzo, S.; Ronca, R.; Presta, M.; Mor, M.; Giacomini, A. | |
| Discovery of novel FGF trap small molecules endowed with anti-myeloma activity | 1-gen-2024 | Taranto, Sara; Castelli, Riccardo; Marseglia, Giuseppe; Scalvini, Laura; Vacondio, Federica; Gianoncelli, Alessandra; Ribaudo, Giovanni; Faletti, Jessica; Gazzaroli, Giorgia; Rocca, Edoardo; Ronca, Roberto; Rusnati, Marco; Sacco, Antonio; Roccaro, Aldo Maria; Presta, Marco; Mor, Marco; Giacomini, Arianna; Rivara, Silvia | |
| Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. | 1-gen-2019 | Fumarola, C; Bozza, N; Castelli, R; Ferlenghi, F; Marseglia, Giuseppe; Lodola, A; Bonelli, M; La Monica, S; Cretella, D; Alfieri, R; Minari, R; Galetti, M; Tiseo, M; Ardizzoni, A; Mor, M; Petronini, Pg. | |
| Fibroblast growth factor receptor inhibitors: patent review (2015–2019) | 1-gen-2019 | Marseglia, Giuseppe; Lodola, Alessio; Mor, Marco; Castelli, Riccardo |